首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目收费,不能显示细节,电话15274084725)
药品名称:
商品名称:
药品NDC:
报告期内:
-
格式:2020-5-3
NDC包装id:
市场分类:
不限
ANDA
BLA
NDA
EMERGENCY USE AUTHORIZATION
NDA AUTHORIZED GENERIC
OTC MONOGRAPH FINAL
OTC MONOGRAPH NOT FINAL
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
UNAPPROVED DRUG OTHER
UNAPPROVED HOMEOPATHIC
UNAPPROVED MEDICAL GAS
活性成分:
持证企业:
美国药品NDC(国家药品编码)与药品说明书数据库
美国NDC未完成药物数据库文件
美国NDC复合药物数据库文件
美国NDC 数据库排除药物数据库文件
 美国NDC复合药物数据库文件1279条(本栏目收费,不能显示细节,电话15274084725)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Fentanyl 20mcg/ml in NS
HUMAN COMPOUNDED DRUG
71286-2074
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 ug/1 mL
71286-2074-1
Midazolam 1mg/ml in D5W
HUMAN COMPOUNDED DRUG
71286-4036
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
MIDAZOLAM HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
71286-4036-1
Midazolam 1mg/ml in NS
HUMAN COMPOUNDED DRUG
71286-4035
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
MIDAZOLAM HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
71286-4035-3
Midazolam 1mg/ml in NS
HUMAN COMPOUNDED DRUG
71286-4035
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
MIDAZOLAM HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
71286-4035-2
Midazolam 1mg/ml in NS
HUMAN COMPOUNDED DRUG
71286-4035
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
MIDAZOLAM HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
71286-4035-5
Neostigmine Methyl Sulfate 1 mg/mL
HUMAN COMPOUNDED DRUG
70004-750
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
NEOSTIGMINE METHYLSULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
70004-750-09
Norepinephrine 16 mcg/mL in 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-771
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
NOREPINEPHRINE BITARTRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.016 mg/1 mL
70004-771-40
Norepinephrine 16 mcg/mL in 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-771
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
NOREPINEPHRINE BITARTRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.016 mg/1 mL
70004-771-44
Norepinephrine 32 mcg/mL in 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-774
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
NOREPINEPHRINE BITARTRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.032 mg/1 mL
70004-774-40
Norepinephrine 64 mcg/mL in 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-775
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
NOREPINEPHRINE BITARTRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.064 mg/1 mL
70004-775-40
Potassium Chloride 20 Meq added to 0.9 % Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-832
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
POTASSIUM CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 meq
70004-832-40
Vancomcyin 1.25 g added to 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
70004-923
SCA Pharmaceuticals, LLC
2021/2/1 0:00:00
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1.25 g
70004-923-59
Trophamine 2.5%/Dextrose 10% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag
HUMAN COMPOUNDED DRUG
72196-0418
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; HEPARIN SODIUM; CALCIUM GLUCONATE MONOHYDRATE; GLUTAMIC ACID; LYSINE ACETATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.2375 g/250 mL; .0275 g/250 mL; .15 g/250 mL; .2625 g/250 mL; .015 g/250 mL; .3 g/250 mL; .75 g/250 mL; .01563 g/250 mL; 25 g/250 mL; .875 g/250 mL; .2125 g/250 mL; .425 g/250 mL; .2 g/250 mL; .5125 g/250 mL; .3375 g/250 mL; .225 g/250 mL; .3 g/250 mL; .125 g/250 mL; .4875 g/250 mL; 125 U/250 mL; 3.75 meq/250 mL; .3125 g/250 mL; .75 g/250 mL
72196-0418-1
Trophamine 3% / Dextrose 5% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag
HUMAN COMPOUNDED DRUG
71285-0419
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; GLUTAMIC ACID; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; CALCIUM GLUCONATE MONOHYDRATE; HEPARIN SODIUM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.405 g/250 mL; .27 g/250 mL; .36 g/250 mL; .15 g/250 mL; .585 g/250 mL; .375 g/250 mL; .9 g/250 mL; .285 g/250 mL; .033 g/250 mL; .18 g/250 mL; .315 g/250 mL; .018 g/250 mL; .36 g/250 mL; .9 g/250 mL; .01875 g/250 mL; 12.5 g/250 mL; 1.05 g/250 mL; .255 g/250 mL; .51 g/250 mL; .24 g/250 mL; .615 g/250 mL; 3.75 meq/250 mL; 125 U/250 mL
71285-0419-1
Epinephrine 4mg added to NS
HUMAN COMPOUNDED DRUG
71285-8093
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
EPINEPHRINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4 mg/250 mL
71285-8093-1
Trophamine 4% / Dextrose 10% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag
HUMAN COMPOUNDED DRUG
71285-0422
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
LYSINE ACETATE; SERINE; GLUTAMIC ACID; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; CALCIUM GLUCONATE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; HEPARIN SODIUM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1.2 g/250 mL; .38 g/250 mL; .5 g/250 mL; .044 g/250 mL; .24 g/250 mL; .42 g/250 mL; .024 g/250 mL; .48 g/250 mL; 1.2 g/250 mL; .025 g/250 mL; 25 g/250 mL; 3.75 meq/250 mL; 1.4 g/250 mL; .34 g/250 mL; .68 g/250 mL; .32 g/250 mL; .82 g/250 mL; .54 g/250 mL; .36 g/250 mL; .48 g/250 mL; .2 g/250 mL; .78 g/250 mL; 125 U/250 mL
71285-0422-1
Maintenance 4 to1 Low K (30 meq) In PL A
HUMAN COMPOUNDED DRUG
72196-0211
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
LIDOCAINE HYDROCHLORIDE; SODIUM BICARBONATE; SODIUM ACETATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM GLUCONATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg/1047 mL; 1.848 g/1047 mL; 3.68 g/1047 mL; 2.605 g/1047 mL; .3 g/1047 mL; 5.26 g/1047 mL; 5.02 g/1047 mL
72196-0211-1
Epinephrine 4mg added to NS
HUMAN COMPOUNDED DRUG
72196-8093
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
EPINEPHRINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4 mg/250 mL
72196-8093-1
Norepinephrine 8mg added to NS
HUMAN COMPOUNDED DRUG
72196-8096
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
NOREPINEPHRINE BITARTRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
8 mg/250 mL
72196-8096-1
Norepinephrine 4mg added to NS
HUMAN COMPOUNDED DRUG
72196-8097
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
NOREPINEPHRINE BITARTRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4 mg/250 mL
72196-8097-1
首页
(current)
44
(current)
45
(current)
46
(current)
47
(current)
48
(current)
49
(current)
50
(current)
51
(current)
52
(current)
53
(current)
(current)
末页
(current)
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
国家药品监督管理局
|
国家中医药管理局
|
SDA药品评审中心
|
医加医疗器械
|
膏药生产厂家
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:33068302000535
医药代理商群1:
医药代理商群2:
医药代理商群3: